California 2021-2022 Regular Session

California Assembly Bill AB381

Introduced
2/2/21  
Introduced
2/2/21  
Refer
2/12/21  
Refer
2/12/21  
Report Pass
3/24/21  
Report Pass
3/24/21  
Refer
3/26/21  
Refer
4/5/21  
Refer
4/5/21  
Report Pass
4/14/21  
Report Pass
4/14/21  
Engrossed
4/22/21  
Engrossed
4/22/21  
Refer
4/26/21  
Refer
4/26/21  
Refer
5/12/21  
Refer
5/12/21  
Report Pass
6/10/21  
Report Pass
6/10/21  
Refer
6/14/21  
Report Pass
6/23/21  
Report Pass
6/23/21  
Refer
6/23/21  
Refer
6/23/21  
Enrolled
9/1/21  
Enrolled
9/1/21  
Chaptered
10/1/21  
Passed
10/1/21  

Caption

Licensed facilities: duties.

Impact

The bill amends provisions within the Health and Safety Code relating to the provision of nonmedical services at recovery facilities. By instituting these requirements, AB 381 seeks to establish a framework that facilitates rapid response to life-threatening opioid overdoses, thereby enhancing the safety of residents. Furthermore, staff members trained in naloxone administration are protected from civil and criminal liability when administering the drug in good faith, promoting a more vigilant and prepared staff environment.

Summary

Assembly Bill 381, approved on October 1, 2021, aims to enhance safety protocols at licensed facilities that serve individuals recovering from substance use disorders. The bill mandates that these facilities maintain at least two unexpired doses of naloxone, an opioid antagonist, at all times on their premises. Additionally, at least one staff member must be trained in administering naloxone and must know its location, thereby equipping facilities to promptly respond to opioid overdose incidents among residents. This legislative move comes in response to increasing opioid-related emergencies, with the aim of safeguarding individuals undergoing recovery.

Sentiment

The sentiment appears largely positive, reflecting a critical need for enhanced safety measures in the context of rising opioid overdoses. Advocates for the bill argue that it promotes proactive healthcare measures, ensuring that facilities can effectively address emergencies. Conversely, while there is strong support for the provision of training and naloxone availability, some concerns have been raised regarding the adequacy of resources and training available to staff at all facilities, particularly smaller or underfunded ones.

Contention

While many stakeholders support the bill for its focus on improving safety and emergency responsiveness, there are underlying issues regarding the execution of these measures. Critics highlight potential shortcomings, such as the challenge of ensuring that all facilities can comply with the mandates given their diverse operational capacities. Additionally, ensuring equitable training opportunities across varying facility sizes is a point of contention that could affect the bill's overall efficacy, as smaller organizations may struggle with the swift implementation of the required measures.

Companion Bills

No companion bills found.

Similar Bills

CA AB1037

Public health: substance use disorder.

CA AB2918

Alcohol and drug abuse treatment or recovery facilities.

CA AB2995

Public health: alcohol and drug programs.

CA SB34

Residential treatment facilities.

CA AB423

Alcoholism or drug abuse recovery or treatment programs and facilities: disclosures.

CA SB43

Substance use disorder: addiction treatment referral agencies.

CT HB05053

An Act Concerning Opioids And Access To Overdose Reversal Drugs.

CA SB234

Opioid antagonists: stadiums, concert venues, and amusement parks.